Label Changes for:
Isentress (raltegravir potassium) tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010
- Musculoskeletal and Connective Tissue Disorders: rhabdomyolysis